Tim Cooke | Chief Executive Officer
Omniose

Pre-Congress Workshops - Monday 1st April @ 10:00

ANTIMICROBIAL RESISTANCE - Role of vaccines, mABs, phages and antibiotics [F2]

A holistic approach will be integral to tackling the AMR pandemic – how is industry ensuring the development of new tools & which interventions are best suited to our priority pathogens? 

Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS

×

Jomana Musmar / ANTIMICROBIAL RESISTANCE - Role of vaccines, mABs, phages and antibiotics [F2]

Jomana Musmar, Executive Director,
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS

Dr. Jomana Musmar serves as the Designated Federal Officer and Executive Director of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria--a US federal advisory committee addressing all issues related to AMR through a One Health approach. Dr. Musmar also serves as a Senior...

CloseMore

Steven Theriault, Chief Executive Officer & Chief Science Officer, Cytophage Technologies

Jim Wassil, Chief Operating Officer, Vaxcyte

Richard Alm, Alliance Director, CARB-X

×

Richard Alm / ANTIMICROBIAL RESISTANCE - Role of vaccines, mABs, phages and antibiotics [F2]

Richard Alm, Alliance Director,
CARB-X

Richard joined CARB-X following almost 20 years in large pharma Infection R&D teams followed by 4 years at a small antibacterial biotech company where he supported the progression of small molecule compounds from discovery through to late-stage clinical development and registration.  He...

CloseMore

Leonard Friedland, Vice President of Scientific Affairs and Public Health Vaccines, GSK

Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader, GVGH

×

Francesca Micoli / ANTIMICROBIAL RESISTANCE - Role of vaccines, mABs, phages and antibiotics [F2]

Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader,
GVGH

PhD in industrial organic chemistry awarded at the University of Florence, Italy, in 2006. More than 15 years experience in the field of vaccines development, focusing her research on bacterial vaccines against AMR pathogens mainly affecting impoverished communities. Involved in the development of...

CloseMore

Tim Cooke, Chief Executive Officer, Omniose

×

Tim Cooke / ANTIMICROBIAL RESISTANCE - Role of vaccines, mABs, phages and antibiotics [F2]

Tim Cooke, Chief Executive Officer,
Omniose

Dedicated to improving human health by leveraging innovations in biotechnology to fight disease. Tim has pursued this goal working in large and small companies and serving on advisory committees that shape national and global policies.

Close

Bret Sellman, Head of Bacteriology, Astrazeneca